The expression of IGF2, a neurotrophic factor, is reduced in people with Alzheimer’s disease (AD) (Pascual-Lucas et al., 2014; Xia et al., 2019). Here, IGF2 is linked to early-onset autosomal dominant Alzheimer disease.